CRSP
$49.25-4.41%
CRISPR Therapeutics AG monthly returns
CRISPR Therapeutics AG has averaged 2.45% per month, positive in 51% of months. Month-by-month returns for CRISPR Therapeutics AG (CRSP) below, through October 16, 2026 — the table lists the most recent months; the bar chart plots the last 5 years.
Average month
+2.4%
118 months
Best month
+71.4%
Nov 2023
Worst month
-26.1%
Oct 2018
Positive months
51%
of all months
CRISPR Therapeutics AG monthly returns#
| Month | Path | Total return |
|---|---|---|
| Oct 2026 | -11.0% | |
| Sep 2026 | -2.9% | |
| Aug 2026 | +18.7% | |
| Jul 2026 | -12.0% | |
| Jun 2026 | -2.9% | |
| May 2026 | +7.3% | |
| Apr 2026 | +10.0% | |
| Mar 2026 | -20.9% | |
| Feb 2026 | +20.4% | |
| Jan 2026 | -4.7% | |
| Dec 2025 | -1.9% | |
| Nov 2025 | -16.4% | |
| Oct 2025 | -1.3% | |
| Sep 2025 | +25.0% | |
| Aug 2025 | -7.9% | |
| Jul 2025 | +15.7% | |
| Jun 2025 | +34.0% | |
| May 2025 | -6.2% | |
| Apr 2025 | +13.6% | |
| Mar 2025 | -22.5% | |
| Feb 2025 | +5.6% | |
| Jan 2025 | +5.7% | |
| Dec 2024 | -23.1% | |
| Nov 2024 | +10.3% | |
| Oct 2024 | -1.3% | |
| Sep 2024 | -1.6% | |
| Aug 2024 | -16.7% | |
| Jul 2024 | +6.1% | |
| Jun 2024 | +0.5% | |
| May 2024 | +1.4% | |
| Apr 2024 | -22.3% | |
| Mar 2024 | -19.1% | |
| Feb 2024 | +33.8% | |
| Jan 2024 | +0.6% | |
| Dec 2023 | -6.2% | |
| Nov 2023 | +71.4% | |
| Oct 2023 | -14.2% | |
| Sep 2023 | -9.2% | |
| Aug 2023 | -12.8% | |
| Jul 2023 | +2.1% | |
| Jun 2023 | -12.3% | |
| May 2023 | +30.9% | |
| Apr 2023 | +8.2% | |
| Mar 2023 | -8.3% | |
| Feb 2023 | -3.3% | |
| Jan 2023 | +25.5% | |
| Dec 2022 | -25.8% | |
| Nov 2022 | +4.7% | |
| Oct 2022 | -19.9% | |
| Sep 2022 | +0.4% | |
| Aug 2022 | -13.2% | |
| Jul 2022 | +23.4% | |
| Jun 2022 | +4.7% | |
| May 2022 | +17.0% | |
| Apr 2022 | -20.9% | |
| Mar 2022 | +2.3% | |
| Feb 2022 | -3.7% | |
| Jan 2022 | -15.9% | |
| Dec 2021 | -5.2% | |
| Nov 2021 | -12.5% | |
| Oct 2021 | -18.4% | |
| Sep 2021 | -10.4% | |
| Aug 2021 | +3.2% | |
| Jul 2021 | -25.2% | |
| Jun 2021 | +37.0% | |
| May 2021 | -10.0% | |
| Apr 2021 | +7.7% | |
| Mar 2021 | -3.1% | |
| Feb 2021 | -24.1% | |
| Jan 2021 | +8.2% | |
| Dec 2020 | +20.6% | |
| Nov 2020 | +38.2% | |
| Oct 2020 | +9.8% | |
| Sep 2020 | -10.5% | |
| Aug 2020 | +9.4% | |
| Jul 2020 | +16.3% | |
| Jun 2020 | +13.8% | |
| May 2020 | +31.3% | |
| Apr 2020 | +16.0% | |
| Mar 2020 | -20.7% | |
| Feb 2020 | +2.9% | |
| Jan 2020 | -14.7% | |
| Dec 2019 | -15.0% | |
| Nov 2019 | +42.2% | |
| Oct 2019 | +22.9% | |
| Sep 2019 | -11.3% | |
| Aug 2019 | -8.8% | |
| Jul 2019 | +7.6% | |
| Jun 2019 | +32.4% | |
| May 2019 | -11.5% | |
| Apr 2019 | +12.5% | |
| Mar 2019 | +0.9% | |
| Feb 2019 | +9.1% | |
| Jan 2019 | +13.5% | |
| Dec 2018 | -25.5% | |
| Nov 2018 | +17.0% | |
| Oct 2018 | -26.1% | |
| Sep 2018 | -21.7% | |
| Aug 2018 | +18.7% | |
| Jul 2018 | -18.8% | |
| Jun 2018 | -14.7% | |
| May 2018 | +47.1% | |
| Apr 2018 | +2.5% | |
| Mar 2018 | -5.7% | |
| Feb 2018 | +23.4% | |
| Jan 2018 | +67.3% | |
| Dec 2017 | +23.6% | |
| Nov 2017 | -1.6% | |
| Oct 2017 | +8.0% | |
| Sep 2017 | -12.7% | |
| Aug 2017 | +17.1% | |
| Jul 2017 | +9.2% | |
| Jun 2017 | +17.6% | |
| May 2017 | -20.0% | |
| Apr 2017 | -21.8% | |
| Mar 2017 | -8.3% | |
| Feb 2017 | +33.7% | |
| Jan 2017 | -12.4% | |
| Dec 2016 | -7.1% | |
| Nov 2016 | +19.6% |
Monthly total return (since Nov 2021)#
-60%-40%-20%0%20%40%60%
Nov 2021-13%
Dec 2021-5.2%
Jan 2022-16%2022
Feb 2022-3.7%
Mar 2022+2.3%
Apr 2022-21%
May 2022+17%
Jun 2022+4.7%
Jul 2022+23%
Aug 2022-13%
Sep 2022+0.4%
Oct 2022-20%
Nov 2022+4.7%
Dec 2022-26%
Jan 2023+26%2023
Feb 2023-3.3%
Mar 2023-8.3%
Apr 2023+8.2%
May 2023+31%
Jun 2023-12%
Jul 2023+2.1%
Aug 2023-13%
Sep 2023-9.2%
Oct 2023-14%
Nov 2023+71%
Dec 2023-6.2%
Jan 2024+0.56%2024
Feb 2024+34%
Mar 2024-19%
Apr 2024-22%
May 2024+1.4%
Jun 2024+0.5%
Jul 2024+6.1%
Aug 2024-17%
Sep 2024-1.6%
Oct 2024-1.3%
Nov 2024+10%
Dec 2024-23%
Jan 2025+5.7%2025
Feb 2025+5.6%
Mar 2025-23%
Apr 2025+14%
May 2025-6.2%
Jun 2025+34%
Jul 2025+16%
Aug 2025-7.9%
Sep 2025+25%
Oct 2025-1.3%
Nov 2025-16%
Dec 2025-1.9%
Jan 2026-4.7%2026
Feb 2026+20%
Mar 2026-21%
Apr 2026+10%
May 2026+7.3%
Jun 2026-2.9%
Jul 2026-12%
Aug 2026+19%
Sep 2026-2.9%
Oct 2026-11%
CRISPR Therapeutics AG returns by calendar month#
Every month of every year since 2017, one tick per year on a shared scale; the dark bar is the month's average. Total returns, dividends reinvested.
October 2026 so far: -10.97% — 6th of 10 Octobers since 2017 at the last close; the average October returned -4.5%.
| Month | −75%0+75% | Average | Median | Up | Best | Worst |
|---|---|---|---|---|---|---|
| Jan | +7.3% | +3.1% | 60% | +67.3% 2018 | -15.9% 2022 | |
| Feb | +9.8% | +7.4% | 70% | +33.8% 2024 | -24.1% 2021 | |
| Mar | -10.5% | -8.3% | 20% | +2.3% 2022 | -22.5% 2025 | |
| Apr | +0.6% | +8.0% | 70% | +16.0% 2020 | -22.3% 2024 | |
| May | +8.7% | +4.4% | 60% | +47.1% 2018 | -20.0% 2017 | |
| Jun | +11.0% | +9.2% | 70% | +37.0% 2021 | -14.7% 2018 | |
| Jul | +2.4% | +6.8% | 70% | +23.4% 2022 | -25.2% 2021 | |
| Aug | +0.8% | -2.3% | 50% | +18.7% 2026 | -16.7% 2024 | |
| Sep | -5.5% | -9.8% | 20% | +25.0% 2025 | -21.7% 2018 | |
| Oct | -4.5% | -1.3% | 33% | +22.9% 2019 | -26.1% 2018 | |
| Nov | +17.0% | +10.3% | 67% | +71.4% 2023 | -16.4% 2025 | |
| Dec | -6.5% | -6.2% | 22% | +23.6% 2017 | -25.8% 2022 |
Methodology#
Monthly returns are total returns (dividends reinvested), computed from CRSP's split- and dividend-adjusted month-end closes. The table shows the most recent 120 months and the bar chart the most recent 60. See the year-by-year returns for the annual view. Past performance does not predict future returns; not investment advice.
FAQ#
- What is CRISPR Therapeutics AG's average monthly return?
- CRISPR Therapeutics AG (CRSP) has averaged about 2.45% per month, positive in roughly 51% of months. The best month was Nov 2023 (+71.4%) and the worst was Oct 2018 (-26.1%).
More on CRISPR Therapeutics AG
By month for: S&P 500 · S&P 500 Equal Weight · US Stock Market · Nasdaq-100